Trials / Completed
CompletedNCT03255551
Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients With Hypertension: Prospective, Multicenter, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension
Detailed description
After taking Amozatan (AMS, amlodipine / rozanthin combination) in patients with essential hypertension, the percentage of patients who reached the mean systolic target blood pressure was evaluated
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amosartan | amosartan is a combination of amlodipine, which is a calcium channel blocker (CCB), and rozatan, an angiotensin II receptor antagonist (ARB), and is an antihypertensive agent |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-06-30
- Completion
- 2015-12-31
- First posted
- 2017-08-21
- Last updated
- 2017-08-21
Source: ClinicalTrials.gov record NCT03255551. Inclusion in this directory is not an endorsement.